(Date:11/24/2009)...ire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),...nnouncedthatithassubmittedaMAAtotheEuropeanMedicin...placementtherapyindevelopment,forthetreatmentofTyp...onforvelaglucerasealfathathasbeensubmitted,withpre..., Basedonaglobalsupplyshortageofthecurrentlyapprov...
(Date:11/24/2009)... Connects Customers with Partners Validated to Pro...k Products , Ottawa, ON (...ng provider of products for biological sample coll...nced its new global partner program. The program o...artner community and is designed to help partners ...
(Date:11/23/2009)...of it as origami very high-tech origami. , Resea...d a technique for fabricating three-dimensional, s...ms by coupling photolithography and a self-folding...films, only a few microns thick, offer mechanical ...es of the same material. , "This is a completely ...
(Date:11/23/2009)...ewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: YMI...atidentifiesandadvancesadiverseportfolioofpromisin...t,todayreportedthatCytopia(ASX:CYT)hascommencedenr...rally-administeredJAK1/JAK2inhibitor.Thetrialisbei...osaltomergeCytopiaintoYMhasbeenpreviouslyannounced...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4...y shows median overall survival of 27.5 months, ...ednisone and a 16.9, months overall surviv...evement of survival benefit milestone results in r...d shares of OGXI., , , BOTHELL, WA and VANCOU...rmaceuticals, Inc. (NASDAQ: OGXI ) today announc...
...oes are like Typhoid Mary. They can spread viruses...low fever without themselves getting sick. Scienti...ther it had a virus hitchhiker, but have now disco...n, assistant professor of entomology at Virginia T...the host and invading RNA the strands of code tha...
...Alfred E. Mann Foundation for,Biomedical Engineeri...by,billionaire Alfred E. Mann to establish univers... at elite universities, designed to facilitate bio...iety, today announced the launch of,a Web site ( h...eb site include: , -- Overview of Alfred Man...
Other Biology Technology:OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4Virginia Tech researchers discover how mosquitoes avoid succumbing to viruses they transmit 2Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market 2Heated Processing Chamber from Terra Universal, Inc.
Down Draft Work Station from Terra Universal, Inc.
...acker Intracellular Localization Kit provides a st...ver siRNA, of your design, in an efficient yet non...ents. Subcellular localization and functional inhi...following introduction of the labeled siRNA into m...
Corning Cryo Box For Internal Thread Vials Only,100 Position,1-2 ml,Non-Sterile from Sigma-Aldrich
Biology Products: